Alison Crumblehulme Promoted to Vice President Business Development

The Board of Directors of Mirexus are pleased to announce the promotion of Alison Crumblehulme to Vice President Business Development.  Alison started her career in R&D and then moved into business development while doing an MBA at Queen’s – before joining Mirexus ~2 years ago to lead our Business Development efforts. “Alison has quickly become a key member of the business leadership team at Mirexus, and we felt this change in title better reflects the importance of her role and contribution to the company”, says Dr. Phil Whiting, President & CEO of Mirexus.  “We are all...

read more

Mirexus’ Founder Dr. John Dutcher Receives University of Guelph Innovations of the Year Award.

Mirexus’ founder and physics professor Dr. John Dutcher received the University of Guelph Innovations of the Year Award for his work with nanoparticles. Mirexus’ platform material PhytoSpherix™,  ,which is a natural biopolymer extracted in the form of completely uniform-sized nanoparticles was discovered by Dutcher’s team at the University of Guelph. Read more (press release from UoG).

read more

Mirexus Biotechnologies Inc. raises $12 million to finance factory, fund business development, and deepen R&D

Guelph, ON – June 29, 2017 Mirexus Biotechnologies Inc. (Mirexus) is excited to announce that it has closed an investment round of $12 million.  Mirexus is a safe and natural nanomaterials company based in Guelph, Ontario that is commercializing PhytoSpherix™, a novel technology based on polysaccharide nanoparticles that can be used in a wide variety of markets ranging from cosmetics to nutraceuticals to applications in human health.  The funds will be used to finance a factory to produce PhytoSpherix™, and to fund at least three years of operations as the company grows. GEL Tech (Canada),...

read more

Dr. Karl Klinger receives Talent Edge postdoctoral research award from the Ontario Centres of Excellence

Mirexus is pleased to announce that Dr. Karl Klinger has recently received an OCE Talent Edge postdoctoral research award. The OCE (Ontario Centres of Excellence) Talent Edge award provides 1 year of research funding in industry for top recent PhD graduates. Karl has a PhD in chemistry from University of Natural Resources and Life Sciences, Vienna.  At Mirexus, his focus is on modifying the surface chemistry of Phytospherix™ (a natural carbohydrate) for biomedical applications.

read more

Boris Segalowitch joins Mirexus as Vice President Personal Care

Mirexus is pleased to announce that Boris Segalowitch has joined as Vice President Personal Care. Boris is based in Paris, France and will lead our efforts to expand the use of our innovative products into the Global Personal Care market. Boris brings over 20 years’ experience in Personal Care, including senior roles with some of the world’s leading Personal Care companies (most recently at Clariant and Croda). “We are thrilled that Mirexus has been able to attract someone with Boris’ experience, knowledge and reputation”, says Dr. Phil Whiting, Mirexus CEO. “This is a huge step forward for...

read more

Mirexus Biotechnology to Present at the Biophysical Society of Canada in Montreal, Quebec on 24th-26th May 2017.

MIREXUS is pleased to announce that we will be Presenting at the 3rd Annual Meeting of the Biophysical Society of Canada to be held in Montreal, Quebec from May 24-26, 2017. Dr. Marty Kurylowicz (R&D Manager) will be presenting on “Applications of Phytoglycogen Nanoparticles in Cosmetics, Nutrition and Medicine” on Thursday May 25th 2017. We invite you to take this opportunity to learn more about Mirexus’ Phytoglycogen – a completely natural form of glycogen, sourced and produced from plants. The natural nanoparticles’ unique & desirable properties are highly sought-after...

read more